Cargando…
Repurposing of α1-Adrenoceptor Antagonists: Impact in Renal Cancer
Renal cancer ranks twelfth in incidence among cancers worldwide. Despite improving outcomes due to better therapeutic options and strategies, prognosis for those with metastatic disease remains poor. Current systemic therapeutic approaches include inhibiting pathways of angiogenesis, immune checkpoi...
Autores principales: | Mihalopoulos, Meredith, Dovey, Zachary, Archer, Maddison, Korn, Talia G., Okhawere, Kennedy E., Nkemdirim, William, Funchess, Hassan, Rambhia, Ami, Mohamed, Nihal, Kaplan, Steven A., Mehrazin, Reza, Lundon, Dara, Tsao, Che-Kai, Badani, Ketan K., Kyprianou, Natasha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564811/ https://www.ncbi.nlm.nih.gov/pubmed/32872127 http://dx.doi.org/10.3390/cancers12092442 |
Ejemplares similares
-
Association between chronic kidney disease and COVID-19-related mortality in New York
por: Mohamed, Nihal E., et al.
Publicado: (2021) -
COVID-19 and Kidney Disease: Molecular Determinants and Clinical Implications in Renal Cancer
por: Mihalopoulos, Meredith, et al.
Publicado: (2020) -
The Resilient Child: Sex-Steroid Hormones and COVID-19 Incidence in Pediatric Patients
por: Mihalopoulos, Meredith, et al.
Publicado: (2020) -
Clinical Significance of Extracellular Vesicles in Prostate and Renal Cancer
por: Chen, Tzu-Yi, et al.
Publicado: (2023) -
The Evolving Clinical Management of Genitourinary Cancers Amid the COVID-19 Pandemic
por: Izadmehr, Sudeh, et al.
Publicado: (2021)